Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending May 2015. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibilities (PDMR) in accordance with DTR 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of insider trading activity rather than a financial performance report.
Material Changes
The material change disclosed is a reduction in the American Depositary Shares (ADSs) held by a PDMR. Specifically, D Troy sold 13,251 GSK ADSs at a price of $45.93 per share on May 11, 2015. The company was advised of this transaction on May 12, 2015.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the total remaining ADS holdings of D Troy following the sale of 13,251 shares.
- Confirm the transaction price of $45.93 against the market price on May 11, 2015.
- Review subsequent filings to determine if this transaction was part of a pre-arranged trading plan.